Inhibition of phosphodiesterase 5A by tadalafil improves SIRT1 expression and activity in insulin-resistant podocytes.

[1]  Agnieszka Piwkowska,et al.  Enhancement of cGMP-dependent pathway activity ameliorates hyperglycemia-induced decrease in SIRT1-AMPK activity in podocytes: Impact on glucose uptake and podocyte function , 2022, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.

[2]  M. Saleem,et al.  Hyperglycemic environment disrupts phosphate transporter function and promotes calcification processes in podocytes and isolated glomeruli , 2022, Journal of cellular physiology.

[3]  D. Rogacka.  Insulin resistance in glomerular podocytes: Potential mechanisms of induction. , 2021, Archives of biochemistry and biophysics.

[4]  Agnieszka Piwkowska,et al.  Involvement of nitric oxide synthase/nitric oxide pathway in the regulation of SIRT1-AMPK crosstalk in podocytes: Impact on glucose uptake. , 2021, Archives of biochemistry and biophysics.

[5]  Yu Liu,et al.  SIRT1-mediated deacetylation of NF-κB inhibits the MLCK/MLC2 pathway and the expression of ET-1 thus alleviating the development of coronary artery spasm. , 2020, American journal of physiology. Heart and circulatory physiology.

[6]  A. Naiki‐Ito,et al.  The phosphodiesterase 5 inhibitor tadalafil has renoprotective effects in a rat model of chronic kidney disease , 2020, Physiological reports.

[7]  M. Saleem,et al.  Cathepsin C is a novel mediator of podocyte and renal injury induced by hyperglycemia. , 2020, Biochimica et biophysica acta. Molecular cell research.

[8]  Agnieszka Piwkowska,et al.  Metformin reduces TRPC6 expression through AMPK activation and modulates cytoskeleton dynamics in podocytes under diabetic conditions. , 2019, Biochimica et biophysica acta. Molecular basis of disease.

[9]  Hideyuki Yamamoto,et al.  Tadalafil improves bladder dysfunction and object recognition in rats with pelvic venous congestion , 2019, International journal of urology : official journal of the Japanese Urological Association.

[10]  Kai Huang,et al.  Hyperglycemia-Driven Inhibition of AMP-Activated Protein Kinase &agr;2 Induces Diabetic Cardiomyopathy by Promoting Mitochondria-Associated Endoplasmic Reticulum Membranes In Vivo , 2019, Circulation.

[11]  Ti Wu,et al.  PDE5A Suppresses Proteasome Activity Leading to Insulin Resistance in C2C12 Myotubes , 2019, International journal of endocrinology.

[12]  Q. Tang,et al.  Identification of Core Gene Biomarkers in Patients with Diabetic Cardiomyopathy , 2018, Disease markers.

[13]  K. Andersson.  PDE5 inhibitors – pharmacology and clinical applications 20 years after sildenafil discovery , 2018, British journal of pharmacology.

[14]  A. Lenzi,et al.  The phosphodiesterase 5 inhibitor tadalafil regulates lipidic homeostasis in human skeletal muscle cell metabolism , 2018, Endocrine.

[15]  A. Isidori,et al.  Sildenafil Prevents Podocyte Injury via PPAR-γ-Mediated TRPC6 Inhibition. , 2017, Journal of the American Society of Nephrology : JASN.

[16]  Ruonan Zhai,et al.  Mechanistic Insight and Management of Diabetic Nephropathy: Recent Progress and Future Perspective , 2017, Journal of diabetes research.

[17]  Agnieszka Piwkowska,et al.  SIRT1-AMPK crosstalk is involved in high glucose-dependent impairment of insulin responsiveness in primary rat podocytes. , 2016, Experimental cell research.

[18]  N. Tamimi,et al.  Phosphodiesterase Type 5 Inhibition Reduces Albuminuria in Subjects with Overt Diabetic Nephropathy. , 2016, Journal of the American Society of Nephrology : JASN.

[19]  D. Bani,et al.  Tadalafil reduces visceral adipose tissue accumulation by promoting preadipocytes differentiation towards a metabolically healthy phenotype: Studies in rabbits , 2016, Molecular and Cellular Endocrinology.

[20]  A. Lenzi,et al.  PDE5 Inhibition Ameliorates Visceral Adiposity Targeting the miR-22/SIRT1 Pathway: Evidence From the CECSID Trial. , 2016, The Journal of clinical endocrinology and metabolism.

[21]  D. Féliers,et al.  Tadalafil Integrates Nitric Oxide-Hydrogen Sulfide Signaling to Inhibit High Glucose-induced Matrix Protein Synthesis in Podocytes* , 2015, The Journal of Biological Chemistry.

[22]  Anindita Das,et al.  PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer. , 2015, Pharmacology & therapeutics.

[23]  M. Ashraf,et al.  Tadalafil, a Phosphodiesterase Inhibitor Protects Stem Cells over Longer Period Against Hypoxia/Reoxygenation Injury Through STAT3/PKG-I Signaling. , 2015, Stem cells and development.

[24]  Agnieszka Piwkowska,et al.  Involvement of the AMPK-PTEN pathway in insulin resistance induced by high glucose in cultured rat podocytes. , 2014, The international journal of biochemistry & cell biology.

[25]  Saisudha Koka,et al.  Chronic inhibition of phosphodiesterase 5 with tadalafil attenuates mitochondrial dysfunction in type 2 diabetic hearts: potential role of NO/SIRT1/PGC-1α signaling. , 2014, American journal of physiology. Heart and circulatory physiology.

[26]  Agnieszka Piwkowska,et al.  Insulin stimulates glucose transport via protein kinase G type I alpha-dependent pathway in podocytes. , 2014, Biochemical and biophysical research communications.

[27]  Sjoerd Stallinga,et al.  Re-scan confocal microscopy: scanning twice for better resolution. , 2013, Biomedical optics express.

[28]  S. Chrysant.  Effectiveness and Safety of Phosphodiesterase 5 Inhibitors in Patients with Cardiovascular Disease and Hypertension , 2013, Current Hypertension Reports.

[29]  L. Rosivall,et al.  Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[30]  O. Nativ,et al.  Phosphodiesterase-5 inhibition attenuates early renal ischemia-reperfusion-induced acute kidney injury: assessment by quantitative measurement of urinary NGAL and KIM-1. , 2013, American journal of physiology. Renal physiology.

[31]  Young-Joo Lee,et al.  Effects of experimental hyperlipidemia on the pharmacokinetics of tadalafil in rats. , 2012, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[32]  F. Fedele,et al.  Chronic Inhibition of cGMP Phosphodiesterase 5A Improves Diabetic Cardiomyopathy: A Randomized, Controlled Clinical Trial Using Magnetic Resonance Imaging With Myocardial Tagging , 2012, Circulation.

[33]  Agnieszka Piwkowska,et al.  Hydrogen peroxide induces dimerization of protein kinase G type Iα subunits and increases albumin permeability in cultured rat podocytes , 2012, Journal of cellular physiology.

[34]  M. Chopp,et al.  Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice , 2011, Neuroscience.

[35]  T. Akizawa,et al.  Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in non‐insulin‐dependent Otsuka Long‐Evans Tokushima Fatty rats , 2011, British journal of pharmacology.

[36]  M. Schiffer,et al.  The role of metabolic and haemodynamic factors in podocyte injury in diabetes , 2011, Diabetes/metabolism research and reviews.

[37]  S. Oktar,et al.  The Beneficial Effects of Tadalafil on Renal Ischemia-Reperfusion Injury in Rats , 2010, Urologia Internationalis.

[38]  J. Corbin,et al.  cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action , 2010, Pharmacological Reviews.

[39]  B. Nyström,et al.  Tadalafil increases muscle capillary recruitment and forearm glucose uptake in women with type 2 diabetes , 2010, Diabetologia.

[40]  C. Cobelli,et al.  Downregulation of the Longevity-Associated Protein Sirtuin 1 in Insulin Resistance and Metabolic Syndrome: Potential Biochemical Mechanisms , 2010, Diabetes.

[41]  P. Pfluger,et al.  Metabolic benefits from Sirt1 and Sirt1 activators , 2009, Current opinion in clinical nutrition and metabolic care.

[42]  P. Puigserver,et al.  Concurrent regulation of AMP-activated protein kinase and SIRT1 in mammalian cells. , 2009, Biochemical and biophysical research communications.

[43]  J. Moon,et al.  Effects of Sildenafil on Oxidative and Inflammatory Injuries of the Kidney in Streptozotocin-Induced Diabetic Rats , 2008, American Journal of Nephrology.

[44]  S. Dimmeler,et al.  NO targets SIRT1: a novel signaling network in endothelial senescence. , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[45]  S. Prabhakar,et al.  Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production. , 2007, Journal of the American Society of Nephrology : JASN.

[46]  Jodi H. D. Long,et al.  Nitric oxide increases GLUT4 expression and regulates AMPK signaling in skeletal muscle. , 2007, American journal of physiology. Endocrinology and metabolism.

[47]  C. Baylis,et al.  Increased renal phosphodiesterase-5 activity mediates the blunted natriuretic response to ANP in the pregnant rat. , 2007, American journal of physiology. Renal physiology.

[48]  P. Gorden,et al.  Spectrum of renal diseases associated with extreme forms of insulin resistance. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[49]  N. Vaziri,et al.  Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage. , 2005, Kidney international.

[50]  J. Tavaré,et al.  The human glomerular podocyte is a novel target for insulin action. , 2005, Diabetes.

[51]  Emilio Clementi,et al.  Calorie Restriction Promotes Mitochondrial Biogenesis by Inducing the Expression of eNOS , 2005, Science.

[52]  Brian C. Smith,et al.  Mechanism of Human SIRT1 Activation by Resveratrol* , 2005, Journal of Biological Chemistry.

[53]  M. Zaccolo,et al.  cGMP Catabolism by Phosphodiesterase 5A Regulates Cardiac Adrenergic Stimulation by NOS3-Dependent Mechanism , 2004, Circulation research.

[54]  J. Stȩpiński,et al.  Characterization of Glucose Uptake by Cultured Rat Podocytes , 2004, Kidney and Blood Pressure Research.

[55]  J. Corbin,et al.  Molecular mechanisms and pharmacokinetics of phosphodiesterase-5 antagonists , 2003, Current urology reports.

[56]  N. Ruderman,et al.  Glucose autoregulates its uptake in skeletal muscle: involvement of AMP-activated protein kinase. , 2003, Diabetes.

[57]  G. Guillon,et al.  ATP induces intracellular calcium increases and actin cytoskeleton disaggregation via P2x receptors. , 2001, Cell calcium.

[58]  J. Huidobro-Toro,et al.  Molecular mechanism of cGMP‐mediated smooth muscle relaxation , 2000, Journal of cellular physiology.

[59]  T. Meyer,et al.  Podocyte loss and progressive glomerular injury in type II diabetes. , 1997, The Journal of clinical investigation.

[60]  C. Baylis,et al.  Importance of nitric oxide in the control of renal hemodynamics. , 1996, Kidney international.

[61]  A. Klip,et al.  Disassembly of the actin network inhibits insulin-dependent stimulation of glucose transport and prevents recruitment of glucose transporters to the plasma membrane. , 1994, The Journal of biological chemistry.

[62]  V. Savin,et al.  Measurement of albumin reflection coefficient with isolated rat glomeruli. , 1992, Journal of the American Society of Nephrology : JASN.

[63]  Agnieszka Piwkowska,et al.  Metformin overcomes high glucose-induced insulin resistance of podocytes by pleiotropic effects on SIRT1 and AMPK. , 2018, Biochimica et biophysica acta. Molecular basis of disease.

[64]  Agnieszka Piwkowska,et al.  High glucose increases glomerular filtration barrier permeability by activating protein kinase G type Iα subunits in a Nox4-dependent manner. , 2014, Experimental cell research.

[65]  Eveline H. Shue,et al.  Antenatal maternally-administered phosphodiesterase type 5 inhibitors normalize eNOS expression in the fetal lamb model of congenital diaphragmatic hernia. , 2014, Journal of pediatric surgery.

[66]  G. Camussi,et al.  Insight on the pathogenesis of diabetic nephropathy from the study of podocyte and mesangial cell biology. , 2005, Current diabetes reviews.

[67]  D. Hardie,et al.  AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. , 2005, Cell metabolism.

[68]  F. DeRubertis,et al.  Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats. Evidence for protein kinase C-mediated suppression of the cholinergic response. , 1994, The Journal of clinical investigation.

[69]  J. Stull,et al.  Regulation of smooth muscle contractile elements by second messengers. , 1989, Annual review of physiology.